The epidemiology of GHB and ketamine use in an Australian household survey

International Journal of Drug Policy

Volumn 19, Issue 4, 2008, Pages 311-316

  Degenhardt, Louisa ^a   Dunn, Matthew ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Australia; Epidemiology; GHB; Household survey; Ketamine; Polydrug use

Indexed keywords

4 HYDROXYBUTYRIC ACID; KETAMINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DEMOGRAPHY; DRUG ABUSE; DRUG DEPENDENCE; DRUG USE; FEMALE; HEALTH SURVEY; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGE FACTORS; AUSTRALIA; DATA COLLECTION; FEMALE; HUMANS; KETAMINE; MALE; PREVALENCE; SODIUM OXYBATE; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 47049126918     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.08.007     Document Type: Article

References (45)

1. Australian Bureau of Criminal Intelligence. (2000). Australian Illicit Drug Report 1998-1999. Canberra: Australian Bureau of Criminal Intelligence.
2. Australian Institute of Health and Welfare. 2001 National Drug Strategy Household Survey: First results (2002), Australian Institute of Health (Drug Statistics Series), Canberra
3. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: First results (2005), Australian Institute of Health and Welfare, Canberra
4. Brown L.P. Pulse check: National trends in drug abuse (1995), Office of National Drug Control Policy, Washington
5. Crysell A. Lost in the K-hole. Muzik 40 (1998) 45-48
6. Curran V., and Monaghan L. In and out of the K-hole a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 95 (2001) 749-760
7. Curran V., and Morgan C. Cognitive, dissociative and psychogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 95 (2000) 575-590
8. Dalgarno P.J., and Shewan D. Illicit use of ketamine in Scotland. Journal of Psychoactive Drugs 28 (1996) 191-199
9. Darke S. Self-report among injecting drug users: A review [see comments]. Drug & Alcohol Dependence 51 (1998) 253-263 (discussion 267-268)
10. Degenhardt L., Barker B., and Topp L. Patterns of ecstasy use in Australia: Findings from a national household survey. Addiction 99 (2004) 187-195
11. Degenhardt L., Copeland J., and Dillon P. The epidemiology of "club drug" use: An Australian review. Substance Use & Misuse 40 (2005) 1241-1256
12. Degenhardt L., Darke S., and Dillon P. GHB use among Australians: Characteristics, use patterns, and associated harm. Drug & Alcohol Dependence 67 (2002) 89-94
13. Degenhardt L., Darke S., and Dillon P. The prevalence and correlates of GHB overdose among Australian users. Addiction 98 (2003) 199-204
14. Degenhardt, L., McGuigan, D., & Clayton, S. (2005). Rapid assessment of trends in crystal methamphetamine and GHB use in the gay, lesbian, bisexual and transgender community in New South Wales. NDARC Technical Report No. 235. Sydney: National Drug and Alcohol Research Centre, University of NSW.
15. Degenhardt, L., Stafford, J., Kinner, S., Johnston, J., Agaliotis, M., & Fry, C. (2005). Reflections on a two-year national pilot study of the Party Drugs Initiative (PDI). NDARC Technical Report No. 236. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
16. Dillon P., Copeland J., and Jansen K.L.R. Patterns of use and harms associated with non-medical ketamine use. Drug & Alcohol Dependence 69 (2003) 23-28
17. Dotson J.W., Ackerman D.L., and West L.J. Ketamine abuse. Journal of Drug Issues 25 (1995) 751-757
18. Drug Enforcement Agency. Ketamine abuse increasing (1997), Drug Enforcement Agency
19. Duff C. "Charging" and "blowing out": Patterns and cultures of GHB use in Melbourne, Australia. Contemporary Drug Problems 32 (2005) 605-655
20. Duff C. Party drugs and party people: Examining the 'normalization' of recreational drug use in Melbourne, Australia. International Journal of Drug Policy 16 (2005) 161-170
21. Dunn, M., Degenhardt, L., Campbell, G., George, J., Johnston, J., Kinner, S., et al. (2007). Australian trends in ecstasy and related drug markets 2006: Findings from the ecstasy and related drugs reporting system (EDRS). NDARC Monograph 61. Sydney: National Drug and Alcohol Research Centre, University of New South Wales.
22. Dunn M., Degenhardt L., and Stafford J. NSW trends in ecstasy and related drug markets 2005: Findings from the party drugs initiative (PDI) (2006), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
23. EMCDDA. (2002). Report on the risk assessment of ketamine in the framework of the join action on new synthetic drugs. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
24. EMCDDA. France: New development, trends and in-depth information on selected issues (2005), European Monitoring Centre for Drugs and Drug Addiction, Lisbon
25. EMCDDA. Norway: New development, trends and in-depth information on selected issues (2005), European Monitoring Centre for Drugs and Drug Addiction, Lisbon
26. Ferrara S., Tedeschi L., and Frison G. Fatality due to gamma-hydroxybutyric acid (GHB) and heroin intoxication. Journal of Forensic Science 40 (1995) 501-504
27. Kent, J. (1996). The ketamine konundrum. http://users.lycaeum.org/∼lux/alchem/konunb.htm, accessed 6/25/97.
28. Kinner S., and Degenhardt L. Reflections on the development and implementation of an early warning system for ecstasy and related drug markets in Australia. Drug and Alcohol Review 25 (2006) 445-449
29. Maxwell J. The response to club drug use. Current Opinion in Psychiatry 16 (2003) 279-289
30. McCambridge J., Mitcheson L., Winstock A., and Hunt N. Five-year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction 100 (2005) 1140-1149
31. Miotto K., Darakjian J., Basch J., Murray S., Zogg J., and Rawson R. Gamma-hydroxybutyric acid: Patterns of use, effects and withdrawal. American Journal on Addictions 10 (2001) 232-241
32. Miro O., Nogue S., Espinosa G., To-Figueras J., and Sanchez M. Trends in illicit drug emergencies: The emerging role of gamma-hydroxybutyrate. Journal of Toxicology-Clinical Toxicology 40 (2002) 129-135
33. New York State Office of Alcoholism and Substance Abuse Service. Ketamine update (1997), Bureau of Applied Studies-Street Studies Unit, New York
34. Palamar J.J., and Halkitis P.N. A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes. International Journal of Drug Policy 17 (2006) 23-28
35. Skovmand K. Swedes alarmed at ketamine misuse. The Lancet 348 (1996) 122
36. Stafford J., Degenhardt L., Dunn M., Fischer J., George J., Johnston J., et al. Australian trends in ecstasy and related drug markets 2005: Findings from the party drugs initiative (PDI) (2006), National Drug and Alcohol Research Centre, University of New South Wales, Sydney
37. Topp L., Barker B., and Degenhardt L. The external validity of results derived from ecstasy users recruited using purposive sampling strategies. Drug & Alcohol Dependence 73 (2004) 33-40
38. Topp L., Hando J., Dillon P., Roche A., and Solowij N. Ecstasy use in Australia: Patterns of use and associated harm. Drug & Alcohol Dependence (1999) 55
39. Tori S.P. Ketamine abuse. 'Special K' (1996), Great Lakes Organized Crime Law Enforcement Network (MAGLOCLEN), Pennsylvania, Middle Atlantic
40. United Nations Office on Drugs and Crime. (2007). World Drug Report 2006. Vienna: United Nations.
41. US Drug Enforcement Agency. Drug intelligence brief-club drugs: An update (2001), DEA Intelligence Division, Office of Domestic Intelligence, Domestic Strategy Unit
42. Weiner A.L., Vieira L., Mckay C.A., and Bayer M.J. Ketamine abusers presenting to the Emergency Department: A case series. Journal of Emergency Medicine 18 (2000) 447-451
43. White J.M., and Ryan C.F. Pharmacological properties of ketamine. Drug and Alcohol Review 15 (1996) 145-155
44. Whitten L. Conference highlights increasing GHB abuse. NIDA Notes 16 (2001) 10-11
45. Wu L.T., Schlenger W., and Galvin D. Concurrent use of methamphetamine, MDMA, LSD, ketamine. GHB and flunitrazepam among American youths. Drug & Alcohol Dependence 84 (2006) 102-113